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Abstract
BACKGROUND—Ethnic differences in nocturnal blood pressure (BP) dipping may contribute to
the increased risk for adverse cardiovascular events noted in African Americans (AAs). The
DASH (Dietary Approaches to Stop Hypertension) diet has been shown to be efficacious in
lowering clinic and ambulatory BP; however, the effect of the DASH diet on BP dipping is
unclear.
METHODS—One hundred and eighteen men and women with high clinic BP (systolic BP (SBP)
130–159; diastolic BP 85–99) and above ideal body weight were randomized to a DASH diet
intervention or to a usual diet control (UC) condition. Measures of 24-h ambulatory BP were
obtained at baseline and at the end of the 4-month intervention period.
RESULTS—At baseline, AAs (n = 43) displayed blunted nocturnal SBP dipping compared to
Caucasians (CAs; n = 75) and were more likely to be categorized as nondippers (<10% nocturnal
decline in SBP, AAs: 51% vs. CAs: 27%). AAs randomized to the DASH diet intervention
showed a significant improvement in SBP dipping postintervention compared to AAs in the UC
condition (P = 0.04), whereas there was no appreciable change in SBP dipping in CAs (P = 0.72).
Following the intervention, ethnic differences in SBP dipping were no longer statistically
significant (nondipper status: AAs: 44% vs. CAs: 32%; P = 0.19).
CONCLUSIONS—Our study provides preliminary evidence suggesting that in overweight men
and women with high BP, AAs may be especially likely to benefit from augmented SBP dipping
associated with consumption of the DASH diet.
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Cardiovascular disease is the leading cause of morbidity and mortality in the United States1
particularly among African Americans (AAs) as compared to whites.1–3 AAs show higher
nocturnal blood pressure (BP) and a blunted decline in BP from day to night.4–8 This
attenuated decline in night-time BP relative to daytime BP, often referred to as
“nondipping,” is associated with elevated risk for cardiovascular disease in normotensive
and hypertensive populations,9–11 and has been linked to development of subclinical
atherosclerosis,12 left ventricular hypertrophy,13 congestive heart failure,14 and all-cause
mortality.15,16
The etiology of ethnic differences in BP is unclear; however, differences in dietary habits
have been suggested to be one possible contributor.17,18 Lifestyle modification, including
diet and exercise, is the recommended initial intervention strategy for lowering BP.19 In
particular, the DASH (Dietary Approaches to Stop Hypertension) diet, which is rich in fruits
and vegetables, low-fat dairy foods, fiber, and protein, and low in saturated fat, total fat, and
cholesterol, has been found efficacious in reducing BP in hypertensive populations in a
series of feeding studies as well as in free-living situations.20–22 For example, the recently
completed ENCORE (Exercise and Nutrition interventions for CardiOvasculaR hEalth)
study demonstrated a significant decline in clinic and 24-h ambulatory BP among
overweight, unmedicated outpatients with high BP randomly assigned to 4 months of the
DASH diet with or without exercise and weight loss compared to usual diet controls
(UCs).22 However, it remains uncertain as to whether the DASH diet influences nocturnal
BP dipping. The aim of the present study was to determine whether the DASH diet
attenuates ethnic differences in nocturnal BP dipping in a sample of overweight,
unmedicated AA and white participants with high BP, compared to participants randomized
to a UC condition.
METHODS
The trial’s design and methods are presented in detail elsewhere.22 Briefly, the ENCORE
study was a randomized trial comparing the effects of the DASH diet with and without
weight loss. Participants were randomized to one of three conditions: (i) the DASH diet
alone (DASH-A), (ii) the DASH diet combined with behavioral weight management
(DASH-WM), and (iii) the UC; the primary endpoint was clinic BP while other biomarkers
of cardiovascular health, including flow mediated dilation, baroreflex sensitivity, and insulin
resistance served as secondary endpoints. Assessments were obtained prior to randomization
and at the end of the 4-month intervention. Immediately following randomization,
participants entered a 2-week controlled feeding period in which they ate according to their
assigned diet. For the UC and DASH-A conditions, participants consumed study meals
isocalorically, whereas participants in the DASH-WM condition consumed meals at 500-
calorie-per-day deficit to allow for weight loss of one pound per week. Following this
feeding period, participants ate their prescribed diets on their own for the remaining 14
weeks of the study. In the DASH-A condition participants received instruction in modifying
the content of their diet to meet DASH guidelines and were instructed explicitly not to
exercise or to attempt to lose weight. DASH-A participants received weekly 30–45-min
group counseling on the DASH diet and were provided feedback on their dietary adherence.
Those participants in DASH-WM received the same instruction on the DASH diet as the
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DASH-A group; however, their weekly group counseling sessions also included cognitive-
behavioral weight loss strategies (e.g., self-monitoring internal cues of satiation) as well as
supervised exercise sessions three times per week. Participants in the UC condition were
asked to maintain their usual dietary habits for 4 months until they were reassessed and were
told not to change their usual exercise habits or to lose weight. On a biweekly basis, their
weight and BP were monitored and their health habits were assessed to ensure they had not
joined any exercise or weight loss program.
Participants
As described in our previous publication,22 the study sample consisted of 144 healthy, but
overweight, men and women with above-normal BP (mean systolic BP (SBP) 130–159 or
diastolic BP 85–99 mm Hg based on four separate screening visits). Additional inclusion
criteria included being age ≥35 years, a body mass index (BMI) of 25–40 kg/m2, sedentary,
free from any medications known to affect the cardiovascular system, and any medical
comorbidities that would preclude safe participation in the trial. This sub-analysis is limited
to Caucasian (CA) and AAs (ethnicity defined by self-report) for whom daytime and night-
time ambulatory BP readings were obtained at both baseline and postintervention. As noted
in the primary publication of this clinical trial, 18 participants were missing ambulatory BP
data. Additionally, night-time BP measurements were missing from six participants.
Because the other minorities comprised such a small (n = 2) subset of the sample, they were
not included, yielding 118 participants for this analysis. In addition, because only 9 AAs (vs.
32 CAs) were randomized to the DASH-WM condition, DASH-WM, and DASH-A (19
AAs vs. 19 CAs) participants were combined together to facilitate the examination of
intervention effects of a DASH diet intervention on nocturnal BP dipping amongst CA and
AAs.
Ambulatory BP monitoring
To assess diurnal variation in BP, participants wore an Accutracker II (Suntech Medical,
Raleigh, NC) ambulatory BP monitor over a 24-h period.23 This device provided BP
measurements four times per hour during the waking day and two times per hour during
sleep. Daytime and night-time BP measures were differentiated by diary reported sleep/
wake times obtained concurrently. Sleep times were unavailable on (n = 19) participants at
either baseline or postintervention time points. However, in an effort to utilize all available
data, BP measurements were deemed as occurring during the night-time if obtained between
12:00 AM and 6:00 AM.16,24 Mean daytime and night-time systolic SBP and diastolic BP
values were computed based on all valid readings during the measurement periods. BP
measurements were accompanied by a diary entry documenting posture, activity, and
location.
Nocturnal BP dipping was computed as a ratio of daytime BP/night-time BP where a smaller
ratio indicates greater nocturnal decline in BP. The day/night BP ratio provides a continuous
measure of nocturnal decline. For descriptive purposes, participants were also classified as a
either a dipper, defined by decrease in SBP from daytime to night-time values of greater
than or equal to 10%, or a nondipper, classified as having less than a 10% decline in systolic
BP from daytime to night-time BP averages.
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Weight and electrolyte assessment
Body weight was determined by a calibrated digital scale (Detecto; Cardinal Scale
Manufacturing, Webb City, MO). Sodium (Na+) and potassium (K+) intake were estimated
from urinary excretion during a 24-h period.25 In addition, an estimation of glomerular
filtration rate was calculated using a modified MDRD equation.26 Differences in glomerular
filtration rate have been proposed to explain variation in BP and BP dipping.27
Statistical analyses
All analyses were performed using SPSS for Windows (version 17.0; SPSS, Chicago, IL).
Comparisons of baseline characteristics were carried out using independent t-test and χ2
statistics. The effect of intervention was evaluated using general linear model functions.
Separate models were estimated for each outcome. The fixed factor predictor variables in
each model were an intervention indicator variable (DASH intervention vs. UC) and
ethnicity (CA vs. AA). Covariates in each model included the corresponding preintervention
value of the outcome, age, gender, BMI, and posture (% time upright). To test whether the
effects of the intervention on nocturnal BP dipping varies by ethnicity, we tested the
interaction between intervention and ethnicity. This study was not powered to detect
interactions; however, we evaluated it and provide the associated P value. In exploratory
subgroup analyses by ethnicity, we computed separate linear models to further explore
intervention effects on nocturnal BP dipping. Finally, because intervention effects on weight
and 24-h urinary excretion of Na+ and K+ could give rise to changes in nocturnal BP
dipping, separate analyses adjusting for change in BMI and change in electrolyte excretion




Demographic characteristics and ambulatory BP averages for CA and AAs are presented in
Table 1. In this sample AAs were more likely to be female and younger relative to CAs (P’s
< 0.01). In addition, AAs displayed less nocturnal SBP dipping (t (116) = −2.51, P = 0.01)
and were more likely to be characterized as a nondipper when compared to CAs (χ2 (1) =
7.15, P = 0.007). Baseline ethnic differences in day/night SBP ratio remained significant
after adjusting for age, gender, BMI, and posture (F (1, 112) = 8.07, P < 0.01). AAs also
displayed greater 24-h urinary excretion of Na+ and a higher estimated glomerular filtration
rate as compared to CAs (P’s < 0.05).
Table 2 displays baseline demographic characteristics and BP measurements by intervention
condition (DASH intervention vs. controls). There were no significant baseline differences
between conditions with the exception of higher average daytime SBP among those
randomized to the UC condition compared to assigned to DASH interventions (t (116) =
2.63, P = 0.01). Conversely, ethnic differences were observed when looking within
condition: specifically, AAs in the DASH intervention condition had a greater proportion of
females, had a higher BMI, and were younger than the CAs assigned to that condition. In
addition, AAs in the DASH intervention had a lower day/night SBP ratio and thus a greater
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proportion of SBP nondippers (P’s < 0.05). AAs had a higher 24-h urinary excretion of Na+
compared to CAs in UC condition.
Effect of DASH intervention on BP dipping
Table 3 displays postintervention and intervention-related changes in ambulatory BP by
dietary intervention and ethnicity. As reported previously,22 participants randomized to a
DASH diet intervention showed a significant decline in ambulatory BP compared to those in
the UC condition, which remained statistically significant after adjusting for baseline levels
of ambulatory BP, age, gender, BMI, and posture (P’s < 0.05). In addition, there was a trend
suggesting DASH intervention to be associated with improvements in day/night SBP ratio
(F (1, 113) = 3.13, P = 0.08). Participants meeting criteria for high-normal BP or obesity
randomized to the DASH intervention showed similar changes in BP dipping observed in
hypertensive and nonobese individuals, respectively.
Next, we examined whether changes in day/night SBP ratio varied by ethnicity. The
interaction between intervention and ethnicity was below statistical significance (F (1, 109)
= 1.97, P = 0.16). However, because this study was underpowered to detect interaction
effects, in exploratory analyses we examined pre/post differences in ambulatory BP in AAs
and CAs separately. We found that AAs randomly assigned to a DASH diet intervention
showed a greater improvement in SBP dipping when compared to AAs in the UC condition
after adjusting for baseline levels of SBP dipping (F (1, 40) = 4.39, P = 0.04) independent of
age, gender, BMI, and posture (F (1, 36) = 4.58, P = 0.04). However, no differences were
observed for CAs randomized to DASH vs. UC (F (1, 68) = 0.13, P = 0.72). Consequently,
at the end of 4 months of intervention with the DASH diet, AAs were no longer significantly
different from CAs on this measure of nocturnal SBP dipping (F (1, 112) = 1.67, P = 0.20).
Moreover, as a whole sample, differences in proportion of nondippers postintervention by
ethnicity were no longer statistically significant (44% of AAs vs. 32% of CAs; χ2 (1) = 1.75,
P = 0.19).
The role of BMI and 24-h urinary electrolyte excretion
It is possible that intervention-related changes in BMI, Na+, and K+ excretion may account
for the reduction of ethnic differences in day/night SBP and proportion of nondippers
postintervention. Consistent with our prior report,22 the DASH diet intervention was
associated with a greater reduction in BMI relative to the UC group (F (1, 115) = 34.25, P <
0.001). However, when change in BMI was treated as a covariate in evaluating intervention-
related changes in day/night SBP ratio separately in AAs and CAs, AAs in the DASH
intervention continued to display a significant increase in day/ night SBP ratio compared to
AAs in the UC condition (F (1, 36) = 4.34, P = 0.04).
Participants in the DASH diet intervention displayed a greater reduction in 24-h urinary Na+
excretion (F (1, 115) = 12.00, P < 0.01) and a significant increase in 24-h urinary K+
excretion (F (1, 115) = 3.83, P = 0.05) compared to UC controls. However, when compared
across conditions, AAs in the DASH intervention showed little change in 24-h excretion of
Na+ (t (41) = 0.94, P = 0.35) and only a marginal increase in K+ as compared to AAs in the
UC control condition (t (41) = 1.87, P = 0.07). Nevertheless, separate models were
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computed to test whether change in Na+ or K+ accounted for improvements in SBP dipping
among AAs. In this regard, AAs in the DASH intervention continued to display a significant
improvement in SBP dipping relative to AAs in the UC condition after adjustment for
change in Na+ urinary excretion (F (1, 39) = 4.12, P = 0.05). In contrast, when change in 24-
h urinary K+ excretion is included as a covariate, AAs randomized to the DASH intervention
no longer differed statistically from AAs in the UC control (F (1, 39) = 2.99, P = 0.09).
DISCUSSION
A growing literature demonstrates AAs to be at substantially greater risk for cardiovascular
morbidity and mortality compared to CAs.1–3 While the mechanisms underlying this
disparity have yet to be fully elucidated, ethnic differences in nocturnal BP dipping may be
an important contributory factor. In the present study, at preintervention baseline, nocturnal
SBP dipping was significantly blunted in AAs relative to CAs, a finding that is consistent
with several cross-sectional investigations.4,6,8,28,29 In exploratory subgroup analyses, this
study revealed that AAs randomized to the DASH intervention, with or without caloric
restriction, displayed marked improvement in nocturnal SBP dipping relative to AAs in the
UC condition. In contrast, CA participants derived comparatively little intervention-related
benefit in BP dipping. Consequently, at postintervention ambulatory BP assessments, AAs
no longer differed from CAs with respect to nocturnal SBP dipping.
The efficacy of DASH diet in reducing clinic, 24-h ambulatory BP, and mortality among
patients with hypertension has been demonstrated previously.20–22,30 However, few studies
have examined the effect of the DASH diet on nocturnal BP dipping. In one such study,
Moore et al.24 showed significant declines in daytime and night-time SBP in a sample of
healthy community volunteers randomized to an 8-week combination diet (rich in fruits and
vegetables and low-fat dairy foods) vs. a control diet; however, this study failed to detect a
statistically significant interaction between intervention and ethnicity. Interestingly, in a
subgroup analyses, minorities randomized to the combination intervention, 90% of whom
were AA, displayed significant declines in 24-h, daytime, and night-time BP compared to
AAs in the control condition. Conversely, CAs failed to show statistically significant
intervention-related changes in ambulatory BP. Similarly, a sub-analysis of the original
DASH diet feeding trial has shown evidence of ethnicity moderating the BP lowering
benefits associated with the DASH diet.31 In this regard, AAs randomized to the DASH
combination diet showed a greater reduction in clinic SBP compared to CAs, an effect that
was most marked in participants with hypertension.31 In the present study, we observed a
trend for an intervention effect on nocturnal BP dipping (P = 0.08). And while this study
was not powered to detect an interaction between ethnicity and intervention condition, the
fact that the sub-analyses revealed that AAs randomized to the DASH intervention showed a
greater improvement in SBP dipping when compared to AAs in the UC condition provides
intriguing, albeit preliminary, evidence that the DASH intervention may confer a particular
benefit for AAs. That said, interpretation of this modest, preliminary finding should be made
cautiously.
The mechanisms that give rise to ethnic differences in BP dipping remain to be elucidated;
however, environmental (e.g., socioeconomic disparities8), physiologic (e.g., elevated
Prather et al. Page 6






















autonomic activation32), and behavioral (e.g., sleep disturbance28) factors appear to play a
role. Dietary sodium and potassium intake also may be important.33 In a prior report,22 we
noted that our DASH dietary intervention was associated with a reduction in sodium intake
and increase in potassium intake; however, other DASH studies have failed to find this
association.20 In the present study, relative to CAs, AAs displayed greater baseline sodium
intake, as assessed by 24-h urinary excretion, which remained high at postintervention.
Moreover, change in sodium intake from baseline to postintervention did not account for
differences in SBP dipping between AAs in the DASH intervention compared to those in the
UC condition. Conversely, change in potassium intake did attenuate observed differences in
intervention-related improvements in SBP dipping among AAs. While evidence supporting
a link between potassium intake and BP dipping is limited, a prior study found a positive
correlation between the magnitude of decline in SBP during sleep and urinary potassium
excretion.13 Further investigation into the role of potassium in BP dipping, particularly
among overweight AAs with high BP is warranted.
The present findings should be interpreted in the context of several limitations. First, the
effects were modest and derived from a relatively small sample of highly motivated
participants. Second, because this study was not designed to examine ethnic differences
specifically, few AAs were randomized to the DASH-WM condition. Consequently, we
were unable to assess the relative impact of DASH-A compared to DASH-WM on BP
dipping. The heterogeneity of the DASH condition in this sub-analysis (DASH-A and
DASH-WM) is particularly relevant when considering differences in weight loss. As
expected, participants in the DASH intervention showed a greater decrease in BMI relative
to those in the UC; however, in subgroup analyses, adjustment for change in BMI had little
effect on improvements observed in AAs in nocturnal SBP dipping.
In summary, this study replicates prior research showing baseline ethnic disparities in
nocturnal BP dipping, with AAs evidencing blunted BP dipping compared to CAs with high
BP. This study also provides preliminary evidence suggesting that the DASH diet
intervention may improve SBP dipping in overweight AAs with high BP, which in turn,
lessens ethnic differences in nocturnal BP dipping. Future research exploring the
mechanisms by which the DASH diet affects nocturnal BP dipping in both CAs and AAs is
warranted.
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